Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 5
2006 8
2007 7
2008 15
2009 17
2010 22
2011 29
2012 15
2013 27
2014 19
2015 13
2016 10
2017 13
2018 11
2019 17
2020 27
2021 29
2022 21
2023 17

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Results by year

Filters applied: . Clear all
Page 1
Nanomedicines: The magic bullets reaching their target?
Flühmann B, Ntai I, Borchard G, Simoens S, Mühlebach S. Flühmann B, et al. Among authors: simoens s. Eur J Pharm Sci. 2019 Feb 1;128:73-80. doi: 10.1016/j.ejps.2018.11.019. Epub 2018 Nov 20. Eur J Pharm Sci. 2019. PMID: 30465818 Free article. Review.
The necessity for a European definition of drug shortages.
De Weerdt E, Simoens S, Casteels M, Huys I. De Weerdt E, et al. Among authors: simoens s. Int J Pharm Pract. 2018 Aug;26(4):289-290. doi: 10.1111/ijpp.12459. Int J Pharm Pract. 2018. PMID: 29972611 No abstract available.
Tendering and biosimilars: what role for value-added services?
Simoens S, Cheung R. Simoens S, et al. J Mark Access Health Policy. 2019 Dec 22;8(1):1705120. doi: 10.1080/20016689.2019.1705120. eCollection 2020. J Mark Access Health Policy. 2019. PMID: 32002174 Free PMC article. Review.
R&D Costs of New Medicines: A Landscape Analysis.
Simoens S, Huys I. Simoens S, et al. Front Med (Lausanne). 2021 Oct 26;8:760762. doi: 10.3389/fmed.2021.760762. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34765624 Free PMC article. Review.
Economic evaluations of homeopathy: a review.
Viksveen P, Dymitr Z, Simoens S. Viksveen P, et al. Among authors: simoens s. Eur J Health Econ. 2014 Mar;15(2):157-74. doi: 10.1007/s10198-013-0462-7. Epub 2013 Feb 10. Eur J Health Econ. 2014. PMID: 23397477 Review.
Pharmaco-economic aspects of sipuleucel-T.
Simoens S. Simoens S. Hum Vaccin Immunother. 2012 Apr;8(4):506-8. doi: 10.4161/hv.18334. Epub 2012 Feb 16. Hum Vaccin Immunother. 2012. PMID: 22336882 Review.
Personalizing health care: feasibility and future implications.
Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL. Godman B, et al. Among authors: simoens s. BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. BMC Med. 2013. PMID: 23941275 Free PMC article. Review.
Health Economics of Antibiotics.
Simoens S. Simoens S. Pharmaceuticals (Basel). 2010 Apr 29;3(5):1348-1359. doi: 10.3390/ph3051348. Pharmaceuticals (Basel). 2010. PMID: 27713306 Free PMC article. Review.
288 results